PT Bumi Menara Internusa - Dampit FDA Record

Summary

Recent FDA inspections

2 inspections from Mar 1, 2012 to Jan 16, 2018.

NAI

No objectionable conditions or practices were found during the inspection.

VAI

Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.

OAI

Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

PT Bumi Menara Internusa - Dampit and the FDA: common questions

Has PT Bumi Menara Internusa - Dampit received an FDA warning letter?

No FDA warning letter addressed to the name "PT Bumi Menara Internusa - Dampit" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has PT Bumi Menara Internusa - Dampit received an FDA Form 483?

FDA has not published a Form 483 for "PT Bumi Menara Internusa - Dampit" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect PT Bumi Menara Internusa - Dampit?

The most recent FDA inspection on file ended Jan 16, 2018 at Dampit, Malang, Indonesia and was classified NAI. FDA has 2 inspections of PT Bumi Menara Internusa - Dampit on file.